Kazuhiro Kakimi

24PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Nov 28, 2025
Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer.

John D Martin, Koji Nagaoka, Myrofora Panagi

|Nov 26, 2025
NeoPAIR-T: Functional Mapping of Neoantigen-TCR Pairs Using a CRISPR-Engineered Jurkat Reporter System.

Koji Nagaoka, Yukari Kobayashi, Kazuhiro Kakimi

|Aug 27, 2025
Clonal diversity shapes the tumour microenvironment leading to distinct immunotherapy responses in metastatic urothelial carcinoma.

Takashi Kamatani, Kota Umeda, Tomohiro Iwasawa

|Aug 14, 2025
Prognostic Implications of T Cell Receptor Repertoire Diversity in Cervical Lymph Nodes of Oral Squamous Cell Carcinoma Patients.

Kenichi Kumagai, Yoshiki Hamada, Akihisa Horie

|Jul 30, 2025
Neoantigen mRNA vaccines induce progenitor-exhausted T cells that support anti-PD-1 therapy in gastric cancer with peritoneal metastasis.

Koji Nagaoka, Hideyuki Nakanishi, Hiroki Tanaka

|Jul 11, 2025
Dissecting the Immunological Microenvironment of Glioma Based on IDH Status: Implications for Immunotherapy.

Miyu Kikuchi, Hirokazu Takami, Yukari Kobayashi

Pageof 4

Frequent Collaborators

4 joint publications

Koji Nagaoka

3 joint publications

Sachiyo Nomura

3 joint publications

Yukari Kobayashi

3 joint publications

Hiroyoshi Nishikawa